After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured ...

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

Tris Pharma has reported positive outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol to treat moderate-to-severe ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Quoin Pharmaceuticals, a biotech company with a keen focus on rare diseases, has recently been making waves in the world of dermatology with its treatment for Netherton Syndrome. This rare genetic ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and ...

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient ...